Hormones and progeny of breast tumor cells

References

• van Keep P A. The history and rationale of hormone replacement therapy. Maturitas 1990; 12: 163–170
   PubMed Web of Science ®Google Scholar
• Russo J, Russo I H. The Mammary Gland. Development, Regulation, and Function, M C Neville, C W Daniel. Plenum Publishing, New YorkUSA 1987; 67–93
   Google Scholar
• Chu K C, Tarone R E, Brawley O W. Breast cancer trends of black women compared with white women. Arch Family Med 1999; 8: 521–528
   PubMedGoogle Scholar
• Schneider H PG, Jackisch C. Endocrine management of breast cancer – biology and current practice. Eur Clin Obstet Gynaecol 2005; 1: 102–114
   Google Scholar
• Rosner B, Colditz G A, Willett W C. Reproductive risk factors in a prospective study of breast cancer: the Nurses Health Study. Am J Epidemiol 1994; 139: 819–835
   PubMed Web of Science ®Google Scholar
• Russo J, Russo I H. Development of the human breast. Maturitas 2004; 49: 2–15
   PubMed Web of Science ®Google Scholar
• Russo J, Rivera R, Russo I H. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992; 23: 211–218
   PubMed Web of Science ®Google Scholar
• Russo J, Gusterson B A, Rogers A E, Russo I H, Wellings S R, Van Zwieten M J. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 244–278
   PubMed Web of Science ®Google Scholar
• Russo J, Mills M J, Moussalli M J, Russo I H. Influence of breast development and growth properties in vitro. In vitro Cell Dev Biol 1989; 25: 643–649
   PubMed Web of Science ®Google Scholar
• Russo J, Reina D, Frederick J, Russo I H. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 1988; 48: 2837–2857
   PubMed Web of Science ®Google Scholar
• Kumar V, Stack G S, Berry M, Jin J R, Chambon P. Functional domains of the human estrogen receptor. Cell 1987; 51: 941–951
   PubMed Web of Science ®Google Scholar
• Wellings S R, Jansen M M, Marcum R G. An atlas of sub-gross pathology of the human breast with special reference to possible pre-cancerous lesions. J Natl Cancer Inst 1975; 55: 231–275
   PubMed Web of Science ®Google Scholar
• Russo J, Russo I H. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst 1978; 61: 1451–1459
   PubMed Web of Science ®Google Scholar
• Russo J, Wilgus G, Russo I H. Susceptibility of the mammary gland to carcinogenesis. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 1979; 96: 721–736
   PubMed Web of Science ®Google Scholar
• Russo J, Moral R, Balogh G A, Mailo D, Russo I H. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005; 7: 131–142
   PubMed Web of Science ®Google Scholar
• Russo J, Mailo D, Hu Y F, Balogh G, Sheriff F, Russo I H. Breast differentiation and its implication in cancer prevention. Clin Cancer Res 2005; 11: 931–936s
   PubMed Web of Science ®Google Scholar
• Srivastava P, Russo J, Russo I H. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 1997; 18: 1799–1808
   PubMed Web of Science ®Google Scholar
• Medina D, Kittrell F S. p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 2003; 63: 6140–6143
   PubMed Web of Science ®Google Scholar
• Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res 2004; 10: 380–384s
   Google Scholar
• Sivaraman L, Conneely O M, Medina D, O'Malley B W. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 2001; 98: 12379–12384
   PubMed Web of Science ®Google Scholar
• Ginger M R, Gonzalez-Rimbau M F, Gay J P, Rosen J M. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 2001; 15: 1993–2009
   PubMed Web of Science ®Google Scholar
• Ginger M R, Rosen J M. Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res 2003; 5: 192–197
   PubMed Web of Science ®Google Scholar
• D'Cruz C M, Mood S E, Master S R, et al. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002; 16: 2034–2051
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison S J, Clarke M F, Weissman I L. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105–111
   PubMed Web of Science ®Google Scholar
• Clarke R B, Anderson E, Howell A, Potten C S. Regulation of human breast epithelial stem cells. Cell Prolif 2003; 36(Suppl 1)45–58
   PubMedGoogle Scholar
• Dontu G, Al-Haji M, Abdallah W M, Clarke M F, Wicha M S. Stem cells in normal breast development and breast cancer. Cell Prolif 2003; 36(Suppl 1)59–72
   PubMed Web of Science ®Google Scholar
• Little M, Boice J. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 1999; 151: 218–224
   PubMed Web of Science ®Google Scholar
• Smith G H, Chepko G. Mammary epithelial stem cells. Micr Res Techn 2001; 52: 190–203
   PubMed Web of Science ®Google Scholar
• Böcker W. Preneoplasia of the Breast. Elsevier. 2006, in press
   Google Scholar
• Pelletier G, El Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol Metab 2000; 85: 4835–4840
   PubMed Web of Science ®Google Scholar
• Saji S, Jensen E V, Nilsson S, Rylander T, Warner M, Gustafsson J A. Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci USA 2000; 97: 337–342
   PubMed Web of Science ®Google Scholar
• Boyd M, Hildebrandt R H, Bartow S A. Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res Treat 1996; 37: 243–251
   PubMed Web of Science ®Google Scholar
• Barnes D M. Progress in Pathology, Vol. 2. Churchill Livingstone, Edinburgh 1995
   Google Scholar
• Horwitz K B, Jackson T A, Bain D L, Richer J K, Takimoto G S, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996; 10: 1167–1177
   PubMed Web of Science ®Google Scholar
• Ogawa S, Inoue S, Watanabe T, et al. Molecular cloning and characterization of human estrogen receptor [beta]cx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 1998; 26: 3505–3512
   PubMed Web of Science ®Google Scholar
• Shoker B S, Jarvis C, Clarke R B, et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 1999; 155: 1811–1815
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M. Prospective identification of tumorigenic breast cancer cells. Proc Nat Acad Sci USA 2003; 100: 3983–3988
   PubMed Web of Science ®Google Scholar
• Dontu G, Wicha M S. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 2005; 10: 75–86
   Google Scholar
• Angst B, Marcozzi C, Magee A. The cadherin superfamily: diversity in form and function. J Cell Sci 2001; 114: 629–641
   PubMed Web of Science ®Google Scholar
• Vallorosi C, Day K, Zhao X, et al. Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem 2000; 275: 3328–3334
   PubMed Web of Science ®Google Scholar
• Hennighausen L, Robinson G W. Signaling pathways in mammary gland development. Dev Cell 2001; 1: 467–475
   PubMed Web of Science ®Google Scholar
• Dontu G, Wicha M S. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 2005; 10: 75–86
   Google Scholar
• Allred D C, Mohsin S K, Fuqua S AW. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001; 8: 47–61, http://www.endocrinology-journals.org/
   PubMed Web of Science ®Google Scholar
• Rudland P S. Epithelial stem cells and their possible role in the development of the normal and diseased breast. Histol Histopathol 1993; 8: 385–404
   PubMed Web of Science ®Google Scholar
• Mohsin S K, Hilsenbeck S G, Allred D C. Estrogen receptors and growth control in premalignant breast disease. Modern Pathol 2000; 13: 28A, (abstr 145)
   Google Scholar
• Clarke R B, Howell H, Potten C S, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997; 57: 4987–4991
   PubMed Web of Science ®Google Scholar
• Russo J, Ao X, Grill C, Russo I H. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999; 53: 217–227
   PubMed Web of Science ®Google Scholar
• Fuqua S AW, Witschke C, Zhang Z X, et al. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 2000; 60: 4026–4029
   PubMed Web of Science ®Google Scholar
• Jensen E V, Cheng G, Palmieri C, et al. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Nat Acad Sci USA 2001; 98: 15197–15202
   PubMed Web of Science ®Google Scholar
• Vos C B, ter Haar N T, Rosenberg C, et al. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 1999; 81: 1410–1418
   PubMed Web of Science ®Google Scholar
• Buerger H, Mommers E C, Littmann R, et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 2001; 194: 165–170
   PubMed Web of Science ®Google Scholar
• Cleton-Jansen A M, Buerger H, ter Haar N, et al. Different mechanisms of chromosome 16 loss of heterozygosity in well-versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004; 41: 109–106
   PubMed Web of Science ®Google Scholar
• Goldstein N S, O'Mally B A. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts. A lesion associated with tubular carcinoma. Am J Clin Pathol 1997; 107: 561–566
   PubMed Web of Science ®Google Scholar
• Moinfar F, Man Y G, Bratthauer G L, Ratschek M, Tavassoli F A. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (‘clinging ductal carcinoma in situ’): a simulator of normal mammary epithelium. Cancer 2000; 88: 2072–2081
   PubMed Web of Science ®Google Scholar
• Azzopardi J G. The histogenesis of ‘early’ carcinoma. Problems in Breast Pathology. Major Problems in Pathology, 1st edn. WB Saunders, London 1979; 11: 92–112
   Google Scholar
• Cleton-Jansen A M. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer. Breast Cancer Res 2002; 4: 5–8
   PubMed Web of Science ®Google Scholar
• Millikan R, Dressler L, Geradts J, Graham M. The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat 1995; 35: 65–77
   PubMed Web of Science ®Google Scholar
• Holland R, Peterse J L, Millis R R, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167–180
   PubMed Web of Science ®Google Scholar
• Buerger H, Mommers E C, Littmann R, et al. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am J Clin Pathol 2000; 114: 854–859
   PubMed Web of Science ®Google Scholar
• Buerger H, Simon R, Schäfer K L, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000; 53: 118–121
   PubMedGoogle Scholar
• Devilee P, Cleton-Jansen A M, Cornelisse C J. Ever since Knudson. Trends Genet 2001; 17: 569–573
   PubMed Web of Science ®Google Scholar
• Alison M R, Poulsom R, Forbes S, Wright N A. An introduction to stem cells. J Pathol 2002; 197: 419–423
   PubMed Web of Science ®Google Scholar
• Revankar C M, Cimino D F, Sklar L A, Arterburn J B, Prossnitz E R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625–1630
   PubMed Web of Science ®Google Scholar